Citadel Advisors
CDNA icon

Citadel Advisors’s CareDx CDNA Stock Holding History

Citadel Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,900
Closed -$173K – 12767
2025
Q3 		$173K Buy
+11,900
New +$170K ﹤0.01% 11409
2025
Q2 		– Sell
-5,000
Closed -$88.8K – 12737
2025
Q1 		$88.8K Sell
5,000
-800
-14% -$17.2K ﹤0.01% 11634
2024
Q4 		$124K Sell
5,800
-4,100
-41% -$99.7K ﹤0.01% 11139
2024
Q3 		$309K Sell
9,900
-100
-1% -$2.49K ﹤0.01% 9284
2024
Q2 		$155K Buy
10,000
+2,100
+27% +$25.4K ﹤0.01% 10301
2024
Q1 		$83.7K Buy
7,900
+5,400
+216% +$54K ﹤0.01% 11595
2023
Q4 		$30K Sell
2,500
-2,700
-52% -$22.1K ﹤0.01% 12265
2023
Q3 		$36.4K Sell
5,200
-6,100
-54% -$56.4K ﹤0.01% 12113
2023
Q2 		$96K Sell
11,300
-4,500
-28% -$37.5K ﹤0.01% 11004
2023
Q1 		$144K Sell
15,800
-12,300
-44% -$157K ﹤0.01% 10699
2022
Q4 		$321K Buy
+28,100
New +$416K ﹤0.01% 9169
2022
Q3 		– Sell
-13,400
Closed -$288K – 12689
2022
Q2 		$288K Hold
13,400
– – ﹤0.01% 9896
2022
Q1 		$496K Sell
13,400
-17,500
-57% -$682K ﹤0.01% 9420
2021
Q4 		$1.41M Buy
30,900
+10,300
+50% +$538K ﹤0.01% 7042
2021
Q3 		$1.3M Buy
20,600
+6,300
+44% +$480K ﹤0.01% 7446
2021
Q2 		$1.31M Sell
14,300
-1,100
-7% -$87.4K ﹤0.01% 7650
2021
Q1 		$1.05M Buy
15,400
+9,800
+175% +$761K ﹤0.01% 7991
2020
Q4 		$406K Buy
+5,600
New +$324K ﹤0.01% 8538
2020
Q3 		– Sell
-9,900
Closed -$351K – 10115
2020
Q2 		$351K Sell
9,900
-2,500
-20% -$71.1K ﹤0.01% 7659
2020
Q1 		$271K Sell
12,400
-1,500
-11% -$33.6K ﹤0.01% 7507
2019
Q4 		$300K Buy
13,900
+1,800
+15% +$41.3K ﹤0.01% 7583
2019
Q3 		$274K Sell
12,100
-6,200
-34% -$172K ﹤0.01% 7685
2019
Q2 		$659K Buy
+18,300
New +$586K ﹤0.01% 6379

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's CDNA Position: Q2 2026 in Review

Citadel Advisors increased its CareDx (CDNA) stake by 27% in Q2 2026, buying an estimated $497K and bringing the position to 106,984 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #5664.

Citadel Advisors first reported a position in CDNA in Q1 2018 and has held it in 31 quarters since. The position peaked at $24.7M in Q3 2021. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Citadel Advisors held 106,984 shares of CareDx worth $3.05M as of Q2 2026.
  • Citadel Advisors bought 22,811 CareDx shares in Q2 2026, an estimated $497K.
  • CareDx made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5664 holding.
  • Citadel Advisors first reported a position in CareDx in Q1 2018 and has held it in 31 quarters since.
  • Citadel Advisors's CareDx position peaked at $24.7M in Q3 2021.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.